Amanote Research
Register
Sign In
Treat and Extend Treatment Interval Patterns With Anti-Vegf Therapy in nAMD Patients
Vision (Switzerland)
- Switzerland
doi 10.3390/vision3030041
Full Text
Open PDF
Abstract
Available in
full text
Categories
Ophthalmology
Cognitive Neuroscience
Optometry
Sensory Systems
Cell Biology
Date
August 26, 2019
Authors
Unknown
Publisher
MDPI AG
Related search
Effects of Smoking on Outcomes of Antivascular Endothelial Growth Factor Therapy in Patients With Neovascular Age-Related Macular Degeneration Smoking and Anti-Vegf Therapy in nAMD
Journal of Ophthalmology
Ophthalmology
Anti-Vegf Therapy in mRCC: Differences Between Asian and Non-Asian Patients
British Journal of Cancer
Cancer Research
Oncology
Anti-Vegf Therapy in Central Retinal Vein Occlusions
International Journal of Retina
An 8-Year Follow-Up of Anti-Vascular Endothelial Growth Factor Treatment With a Treat-And-Extend Modality for Neovascular Age-Related Macular Degeneration
Acta Ophthalmologica
Medicine
Ophthalmology
One-Year Outcomes Comparing Anti-Vegf Monotherapy and Combined Anti-VEGF+Photodynamic Therapy for Retinal Angiomatous Proliferation
Beyoglu Eye Journal
Anti-Vegf Therapy in Breast and Lung Mouse Models of Cancers
Journal of Biomedicine and Biotechnology
Switching Frompro Re Natato Treat-And-Extend Regimen Improves Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration
Acta Ophthalmologica
Medicine
Ophthalmology
Use of Biomaterials for Sustained Delivery of Anti-Vegf to Treat Retinal Diseases
Eye
Medicine
Arts
Sensory Systems
Ophthalmology
Humanities
The Potential of Anti-Vegf (Vasotide) by Eye Drops to Treat Proliferative Retinopathies
Annals of Translational Medicine
Medicine
